Mahin Badakhsh1, Fereshteh Daneshi2, Mahnaz Abavisani3, Hosien Rafiemanesh4, Salehoddin Bouya5, Mahmood Sheyback6, Khadije Rezaie Keikhaie7, Abbas Balouchi8. 1. Department of Midwifery, School of Nursing and Midwifery, Zabol University of Medical Science, Zabol, Iran. 2. Department of Pediatric Nursing, School of Nursing and Midwifery, Jiroft University of Medical Sciences, Jiroft, Iran. 3. MSc of Medical Surgical Nursing, Neyshabur University of Medical Sciences, Neyshabur, Iran. 4. Student Research Committee, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 5. Clinical Immunology Research Center, Ali-ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran. 6. Bushehr University of Medical Sciences, Bushehr, Iran. 7. Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran. kanregeli@gmail.com. 8. Student Research Committee, Nursing and Midwifery School, Iran University of Medical Sciences, Tehran, Iran.
Abstract
PURPOSE: Gestational diabetes mellitus (GDM) is one of the costly challenges in the health field. Despite the individual studies in the Eastern Mediterranean, there is no comprehensive study in this regard. The aim of this study was to determine the prevalence of GDM in the Eastern Mediterranean region. METHODS: In this meta-analysis and systematic review, three international databases (PubMed, Web of science and Scopus) were searched from inception until 30 December 2018. The Hui tool was used to assess the quality of the included studies. RESULTS: Thirty-three studies performed on 887166 participants were included in the meta-analysis. Based on the results of random effect method, the overall prevalence of GDM was 11.7%. Between six country with have three or more study, pooled prevalence for Saudi Arabi it was 3.6 times more than Israel (17.6 vs. 4.9%), and for Pakistan, Qatar, Bahrain and Iran were 15.3%, 14.7%, 12.2%, and 8.6%, respectively. CONCLUSION: Despite the high diversity of methods, the results of the present study indicate a high prevalence of GDM in the Eastern Mediterranean region, indicating more policymakers' interest in timely screening and proper management.
PURPOSE:Gestational diabetes mellitus (GDM) is one of the costly challenges in the health field. Despite the individual studies in the Eastern Mediterranean, there is no comprehensive study in this regard. The aim of this study was to determine the prevalence of GDM in the Eastern Mediterranean region. METHODS: In this meta-analysis and systematic review, three international databases (PubMed, Web of science and Scopus) were searched from inception until 30 December 2018. The Hui tool was used to assess the quality of the included studies. RESULTS: Thirty-three studies performed on 887166 participants were included in the meta-analysis. Based on the results of random effect method, the overall prevalence of GDM was 11.7%. Between six country with have three or more study, pooled prevalence for Saudi Arabi it was 3.6 times more than Israel (17.6 vs. 4.9%), and for Pakistan, Qatar, Bahrain and Iran were 15.3%, 14.7%, 12.2%, and 8.6%, respectively. CONCLUSION: Despite the high diversity of methods, the results of the present study indicate a high prevalence of GDM in the Eastern Mediterranean region, indicating more policymakers' interest in timely screening and proper management.
Authors: Khalil E Rajab; Abdulla A Issa; Zuheir A Hasan; Ebrahim Rajab; Ahmed A Jaradat Journal: Int J Gynaecol Obstet Date: 2012-01-20 Impact factor: 3.561
Authors: Eliana M Wendland; Maria Regina Torloni; Maicon Falavigna; Janet Trujillo; Maria Alice Dode; Maria Amélia Campos; Bruce B Duncan; Maria Inês Schmidt Journal: BMC Pregnancy Childbirth Date: 2012-03-31 Impact factor: 3.007
Authors: Abdullatif D Ali; Amat Al-Khaleq O Mehrass; Abdulelah H Al-Adhroey; Abdulqawi A Al-Shammakh; Adel A Amran Journal: Int J Womens Health Date: 2016-01-25
Authors: Qian Zhou; Shiwu Wen; Miao Liu; Sulei Zhang; Xin Jin; Aizhong Liu Journal: Int J Environ Res Public Health Date: 2020-12-29 Impact factor: 3.390